Long-term Outcomes and Mixed Response in Nivolumab Therapy for Head and Neck Cancer
This study provides new insights into the long-term efficacy of nivolumab in R/M-HNC, highlighting the favorable prognosis in NPC and in patients outside the CheckMate 141 criteria. Importantly, this study is the first to report the frequency of MR in HNC, with MR being associated with a significantly better prognosis.
Authors
- Shiro Yamazaki (ORCID: https://orcid.org/0000-0001-9389-3669)
- Mariko Kasuga
- Yutaka Takumi (ORCID: https://orcid.org/0000-0003-2874-9796)
- Yoh-ichiro Iwasa (ORCID: https://orcid.org/0000-0001-8989-9021)
- Ryosuke Kitoh (ORCID: https://orcid.org/0009-0004-8123-1835)
- Yoh Yokota
- Kentaro Hori
Institutions
- Shinshu University (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-08-28
- DOI
- https://doi.org/10.21873/invivo.14076
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00